PRAH - PRAヘルス・サイエンシズ (PRA Health Sciences Inc.) PRAヘルス・サイエンシズ

 PRAHのチャート


 PRAHの企業情報

symbol PRAH
会社名 PRA Health Sciences Inc (PRAヘルス・サイエンシズ)
分野(sector) Health Care   ヘルスケア
産業(industry) Biotechnology: Commercial Physical_Biological Resarch  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 PRA ヘルス・サイエンス(PRA Health Sciences Inc)は契約研究機関である。同社はバイオテクノロジー及び製薬業界に委託的臨床開発サービスを提供する。同社は腫瘍、中枢神経系、炎症及び感染症を含む医薬品開発分野における治療サービスを提供する。同社のサービスはデータ管理、統計分析、臨床試験管理と規制及び薬物開発コンサルティングを含む。同社は伝統的・プロジェクトベースの第I相から第IV相までのサービス及び組み込み型・機能型アウトソーシングサービスを含む臨床開発サービスをクライアントに提供する。同社のサービスには製品登録、戦略的ソリューション、初期開発サービス等を含む。   PRAヘルス・サイエンシズは米国の開発業務受託機関(CRO)。世界中のバイオテクノロジ―及び医薬品業界に臨床開発サ―ビスを提供。サ―ビスは、デ―タ管理、統計分析、臨床試験管理、規制及び医薬品開発コンサルティングを含む。がん、中枢神経システム、炎症、感染症疾患での治療学経験があるが、全ての主要な治療分野での臨床試験を実施する能力を保有。   
本社所在地 4130 ParkLake Avenue Suite 400 Raleigh NC 27612 USA
代表者氏名 Colin Shannon コリンシャノン
代表者役職名 Chairman of the Board President Chief Executive Officer 取締役会長兼最高経営責任者(CEO)
電話番号 +1 919-786-8200
設立年月日 41426
市場名 NASDAQ National Market System
ipoyear 2014年
従業員数 15800人
url www.prahs.com
nasdaq_url https://www.nasdaq.com/symbol/prah
adr_tso
EBITDA EBITDA(百万ドル) 386.62800
終値(lastsale) 104.475
時価総額(marketcap) 6725189269.05
時価総額 時価総額(百万ドル) 6202.816
売上高 売上高(百万ドル) 2662.583
企業価値(EV) 企業価値(EV)(百万ドル) 7380.592
当期純利益 当期純利益(百万ドル) 129.91500
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 PRA Health Sciences Inc revenues increased 39% to $1.42B. Net income before extraordinary items increased 54% to $84.6M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Foreign Exchange Gain/Loss?Non-Business increase from $22.2M (expense) to $393K (income).

 PRAHのテクニカル分析


 PRAHのニュース

   The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx  2021/04/29 12:15:49 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ: AXNX ) Boston Scientific Corporation (NYSE: BSX ) (reacted to first-quarter results) Celcuity Inc. (NASDAQ: CELC ) Celldex Therapeutics, Inc. (NASDAQ: CLDX) Galectin Therapeutics Inc. (NASDAQ: GALT ) Horizon Therapeutics Public Limited Company (NASDAQ: HZNP ) Insulet Corporation (NASDAQ: PODD ) Integra LifeSciences Holdings Corporation (NASDAQ: IART ) (announced first-quarter results) Lantheus Holdings, Inc. (NASDAQ: LNTH ) MacroGenics, Inc. (NASDAQ: MGNX ) NuVasive, Inc. (NASDAQ: NUVA) PRA Health Sciences, Inc. (NASDAQ: PRAH ) ShockWave Medical, Inc. (NASDAQ: SWAV ) Verastem, Inc. (NASDAQ: VSTM ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows April 28) Akoya Biosciences, Inc. (NASDAQ: AKYA ) Decibel Therapeutics, Inc. (NASDAQ: DBTX ) IRadimed Corporation (NASDAQ: IRMD ) Lucira Health, Inc. (NASDAQ: LHDX ) Mesoblast Limited (NASDAQ: MESO ) Protara Therapeutics, Inc. (NASDAQ: TARA ) PTC Therapeutics, Inc. (NASDAQ: PTCT ) Stocks In Focus Adverum Shares Sink On Serious Adverse Event Adverum Biotechnologies, Inc. (NASDAQ: ADVM ) announced a suspected unexpected serious adverse reaction of hypotony, which is clinically relevant decrease in ocular pressure, in its INFINITY clinical trial evaluating ADVM-022 gene therapy for the treatment of diabetic macular edema.
   Global Pre-Clinical Contract Research Services Market Growth Status and Outlook by 2026 | Envigo Corporation, MPI research, Eurofins Scientific, PRA Health Sciences, Inc, Wuxi AppTec, Medpace  2021/03/18 11:06:07 OpenPR
The Pre-Clinical Contract Research Services Market delivers a comprehensive study of the market, including its dynamics, structure, characteristics, Key players, growth and demand drivers, etc. As a Complete Analysis report, it covers all details inside analysis and outlook according to
   Robert W. Baird Stick to Their Buy Rating for PRA Health Sciences By Investing.com  2021/03/16 09:03:41 Investing.com
Robert W. Baird Stick to Their Buy Rating for PRA Health Sciences
   INVESTIGATION ALERT: Halper Sadeh LLP Investigates PRAH, MIK, WSFS, TLND, SVBI; Shareholders are Encouraged to Contact the Firm  2021/03/12 03:39:00 PR Newswire
NEW YORK, March 11, 2021 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: PRA Health Sciences, Inc. (NASDAQ: PRAH) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties…
   Dublin will be home to major clinical research following $12bn Icon deal  2021/03/03 09:47:33 SiliconRepublic
Two major contract research organisations will combine as Ireland’s Icon acquires US company PRA Health for $12bn.
   Contract Research Organizations Market Size, Share, Analysis 2027 | Top key players – Laboratory Corporation Of America Holdings (covance), Iqvia, Syneos Health, Paraxel International Corporation, Pra Health Sciences, Pharmaceutical Product Development  2021/02/03 11:32:01 OpenPR
Contract Research Organizations Market Size, Share, Analysis 2027 | Top key players – Laboratory Corporation Of America Holdings (covance), Iqvia, Syneos Health, Paraxel International Corporation, Pra Health Sciences, Pharmaceutical Product Development (ppd), Charles River Laboratories International Inc (crl), Icon
   The Daily Biotech Pulse: Fluidigm's Saliva-Based COVID Test Approved In Europe, China Backs Amarin's Vascepa  2021/01/22 12:22:33 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 21) Acasti Pharma Inc (NASDAQ: ACST ) Alimera Sciences Inc (NASDAQ: ALIM ) argenx SE – ADR (NASDAQ: ARGX ) Axonics Modulation Technologies Inc (NASDAQ: AXNX ) AzurRx BioPharma Inc (NASDAQ: AZRX ) Chimerix Inc (NASDAQ: CMRX ) Edap Tms SA (NASDAQ: EDAP ) Eli Lilly And Co (NYSE: LLY ) (announced positive results for its COVID-19 antibody treatment) ESSA Pharma Inc (NASDAQ: EPIX ) Idera Pharmaceuticals Inc (NASDAQ: IDRA ) Inari Medical Inc (NASDAQ: NARI ) INmune Bio Inc (NASDAQ: INMB ) ( INSM ) Integra Lifesciences Holdings Corp (NASDAQ: IART ) Inventiva ADR Representing Ord Shs (NASDAQ: IVA ) Jounce Therapeutics Inc (NASDAQ: JNCE ) Krystal Biotech Inc (NASDAQ: KRYS ) Laboratory Corp. of America Holdings (NYSE: LH ) Merus NV (NASDAQ: MRUS ) Neuronetics Inc (NASDAQ: STIM ) OncoSec Medical Inc (NASDAQ: ONCS ) (announced common stock offering) PRA Health Sciences Inc (NASDAQ: PRAH ) Precision BioSciences Inc (NASDAQ: DTIL ) Profound Medical Corp (NASDAQ: PROF ) Renalytix AI PLC (NASDAQ: RNLX ) Rhythm Pharmaceuticals Inc (NASDAQ: RYTM ) Seelos Therapeutics Inc (NASDAQ: SEEL ) Surface Oncology Inc (NASDAQ: SURF ) Syneos Health Inc (NASDAQ: SYNH ) Synlogic Inc (NASDAQ: SYBX ) Twist Bioscience Corp (NASDAQ: TWST ) Vericel Corp (NASDAQ: VCEL ) Xencor Inc (NASDAQ: XNCR ) Down In The Dumps None of the biotech/medical device/diagnostic stocks hit 52-week highs in the session.
   The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations  2021/01/13 12:25:38 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 12) AbbVie Inc (NYSE: ABBV ) AcelRx Pharmaceuticals Inc (NASDAQ: ACRX ) Aldeyra Therapeutics Inc (NASDAQ: ALDX ) Alkermes Plc (NASDAQ: ALKS ) AtriCure Inc. (NASDAQ: ATRC ) Bioanalytical Systems, Inc. (NASDAQ: BASI ) BIOLASE Inc (NASDAQ: BIOL ) (announced an agreement to expand laser adoption and hands-on training programs in targeted geographies) CareDx Inc (NASDAQ: CDNA ) Celsius Holdings, Inc. (NASDAQ: CELH ) DermTech Inc (NASDAQ: DMTK ) Dyne Therapeutics Inc (NASDAQ: DYN ) Edap Tms SA (NASDAQ: EDAP ) Evelo Biosciences Inc (NASDAQ: EVLO ) EXACT Sciences Corporation (NASDAQ: EXAS ) Eyenovia Inc (NASDAQ: EYEN ) Genetron Holdings Ltd – ADR (NASDAQ: GTH ) Guardant Health Inc (NASDAQ: GH ) (reacted to presentation at the JPMorgan Healthcare Conference) Intra-Cellular Therapies Inc (NASDAQ: ITCI ) Kaleido Biosciences Inc (NASDAQ: KLDO ) Laboratory Corp.
   Contract Research Organization Market to Witness Huge Growth by 2024| Key Players are IQVIA Holdings, Inc., Laboratory Corporation of America Holdings, Syneos Health Inc, PRA Health Sciences, Medpace Holdings Inc and Wuxi AppTec Co Ltd  2021/01/11 14:21:10 OpenPR
ReportsnReports.com the exclusive leading provider of market research reports published research report on “China Contract Research Organization (CRO) Market (Clinical, Pre-clinical & Discovery): Insights, Trends and Forecast (2020-2024)”. China CRO market value is anticipated to reach US$27.04 billion in 2024, growing
   Pre Clinical CROs market 2027 Top Players : ovance, Inc., Charles River, Eurofins Scientific, PRA Health Sciences  2020/12/09 11:35:55 OpenPR
The global Pre Clinical CROs market is expected to reach US$ 8,412.9 Mn in 2027 from US$ 4,282.4 Mn in 2018. The market is estimated to grow with a CAGR of 8.1% from 2019-2027. The report highlights the trends prevalent
   Pre Clinical CROs market 2027 Top Players : ovance, Inc., Charles River, Eurofins Scientific, PRA Health Sciences  2020/12/09 11:35:55 OpenPR
The global Pre Clinical CROs market is expected to reach US$ 8,412.9 Mn in 2027 from US$ 4,282.4 Mn in 2018. The market is estimated to grow with a CAGR of 8.1% from 2019-2027. The report highlights the trends prevalent
   Contract Research Organizations Services Market to Set Remarkable Growth in Coming Years| Key Players: Laboratory Corporation of America Holdings (Covance), IQVIA, Syneos Health, Paraxel International Corporation, PRA Health Sciences, Pharmaceutical Produ  2020/12/09 10:39:02 OpenPR
Reportsandmarkets.com adds “Global Contract Research Organizations Services Market Insights, Forecast to 2025” new report to its research database. The report spread across 113 pages with multiple tables and figures in it. This report studies the Contract Research Organizations Services market with
   Innovative Research Report on Virtual Clinical Trials Market by Forecast to 2027 | ICON Plc, Oracle, PRA Health Sciences, LEO Innovation Lab, Medable  2020/11/19 13:04:48 OpenPR
Global Virtual Clinical Trials Market Report is recently published by Future Business Insights is a value addition to the studied Market. The compilation of the research report is conditioned by primary and secondary research techniques. The report also elaborates on
   PRA Health Sciences Reports Strong First-Quarter Financial Results Stock market Insights & financial analysis  2020/11/04 13:32:00 Stock Market Daily
PRA Health Sciences announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the conference call and remind yourself by…
   PRA Health Sciences, Inc. (NASDAQ:PRAH) Expected to Post Quarterly Sales of $767.84 Million  2020/10/24 00:46:45 US Banking News
Analysts expect that PRA Health Sciences, Inc. (NASDAQ:PRAH) will report sales of $767.84 million for the current fiscal quarter, Zacks reports. Five analysts have issued estimates for PRA Health Sciences’ earnings. The lowest sales estimate is $763.50 million and the highest is $772.62 million. PRA Health Sciences posted sales of $780.69 million in the same […]

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 PRAヘルス・サイエンシズ PRAH PRA Health Sciences Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)